03:11 , Jan 13, 2018 |  BioCentury  |  Finance

JPM jolt

Fifteen biotechs that presented at the 2018 J.P. Morgan Healthcare Conference posted gains of at least 15%, with Ablynx N.V. (Euronext:ABLX; NASDAQ:ABLX) leading the risers after announcing that its board rejected two unsolicited acquisition proposals...
21:39 , Dec 1, 2017 |  BC Week In Review  |  Clinical News

QIMR reports updated Phase I data for MS candidate

Atara Biotherapeutics Inc. (NASDAQ:ATRA) said QIMR Berghofer Medical Research Institute (Brisbane, Australia) reported updated data from a Phase I trial in 10 patients with primary progressive multiple sclerosis (PPMS) and secondary progressive MS (SPMS) showing...
19:59 , Apr 11, 2017 |  BC Innovations  |  Distillery Techniques

Disease models

TECHNOLOGY: Animal models LMP1/LMP2-overexpressing mice depleted of T cells and NKT cells could be used to screen therapies for EBV-positive lymphoproliferative disease. Mice with germinal center B cell-specific overexpression of LMP1 and LMP2, treated with a...